Minimum tolerable interval of radioimmunotherapy and autologous stem cell transplantation after high-dose chemotherapy for relapsed or refractory aggressive B cell Non-Hodgkin-Lymphoma provides excellent disease control - Hasenkamp, Justin; Witzens-Harig, Mathias (Blood, 2014)
Gesehen am 02.07.2015
Keywords: Konferenzschrift